Review

Advances of macrolide resistant Mycoplasma pneumoniae infection of children

  • WANG Lan ,
  • WU Liang-xia
Expand
  • 1.Department of Paediatrics, Shanghai Putuo District Central Hospital, Shanghai 200062, China; 2.Department of Paediatrics, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai 200233, China

Online published: 2015-06-04

Abstract

Mycoplasma pneumoniae is one of major pathogens causing respiratory tract infection of children and is usually treated with macrolides. Since 2001, reported macrolide resistant isolates of Mycoplasma pneumoniae has increased worldwide, especially in East Asia. This paper reviews the current situation and mechanisms of macrolide resistance of Mycoplasma pneumoniae and clinical characteristics of pediatric patients infected by macrolide resistant Mycoplasma pneumoniae, and discusses the best approach to deal with this situation.

Cite this article

WANG Lan , WU Liang-xia . Advances of macrolide resistant Mycoplasma pneumoniae infection of children[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2015 , 35(5) : 780 . DOI: 11.3969/j.issn.1674-8115.2015.05.030

Outlines

/